Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
曲莫杜林治疗重症 COVID-19 患者的疗效和安全性:一项随机、安慰剂对照、双盲、多中心 II 期试验 (ESsCOVID) 的结果
期刊:European Journal of Medical Research
影响因子:3.4
doi:10.1186/s40001-024-02008-x
Agafina, Alina; Aguiar, Valeria Cristina; Rossovskaya, Maria; Fartoukh, Muriel Sarah; Hajjar, Ludhmila Abrahao; Thiéry, Guillaume; Timsit, Jean-François; Gordeev, Ivan; Protsenko, Denis; Carbone, Javier; Pellegrini, Rita; Stadnik, Claudio Marcel Berdun; Avdeev, Sergey; Ferrer, Miquel; Heinz, Corina C; Häder, Thomas; Langohr, Patrick; Bobenhausen, Iris; Schüttrumpf, Jörg; Staus, Alexander; Ruehle, Markus; Weissmüller, Sabrina; Wartenburg-Demand, Andrea; Torres, Antoni